Rosuvastatin Tablet, Film Coated
Product Images NDC 70518-4098

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Rosuvastatin (NDC 70518-4098). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Remedy_label (Remedy Label)

Remedy_label (Remedy Label)
Rosuvastatin 5 mg film-coated tablets packaging label showing quantity of 90 tablets. Label includes NDC 70518-4098-00, manufacturer ScieGen Pharmaceuticals, and repackager RemedyRepack Inc. Directions and storage instructions are noted, with a barcode and QR code also visible.*
FDA Label Image

Figure-01 (Figure 1)

Figure-01 (Figure 1)
A cumulative incidence plot comparing Rosuvastatin (Rosuva) with placebo over approximately 5 years. The y-axis represents cumulative incidence percentage, and the x-axis shows time in years. The plot includes hazard ratio (HR 0.56) with a 95% confidence interval and P-value, illustrating lower incidence with Rosuvastatin compared to placebo. A risk table below details sample sizes at various time points.*
FDA Label Image

Figure-02 (Figure 2)

Figure-02 (Figure 2)
A data table presenting clinical trial results comparing Rosuvastatin 20 mg to Placebo 20 mg in terms of number of events and event rates per 1000 patient-years. It lists endpoints such as primary endpoint (MCE), cardiovascular death, nonfatal stroke, nonfatal MI, hospitalized unstable angina, and arterial revascularization. The table includes hazard ratios with 95% confidence intervals and p-values, alongside a forest plot visualizing hazard ratios and confidence intervals.*
FDA Label Image

Figure-02 (Figure 3)

Figure-02 (Figure 3)
A box plot chart showing percent change from baseline in LDL-C levels across different statin drugs: Rosuvastatin, Atorvastatin, Simvastatin, and Pravastatin, at various dose levels (mg). The vertical axis represents percent change from 0 to -75, and dosage amounts are indicated above each drug category.*
FDA Label Image

Structural Formula (Rosuvastatin Str)

Structural Formula (Rosuvastatin Str)
Chemical structure diagram of rosuvastatin calcium, showing the molecular framework including aromatic rings, hydroxyl groups, and the calcium ion complexation, representing the active ingredient in rosuvastatin tablets.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.